✦ LIBER ✦

Other novel agents: Rationale and current status as chemopreventive agents

✍ Scribed by Anthony W Tolcher; Ann Kennedy; Robert J Padley; Noreen Majeed; Michael Pollak; Philip W Kantoff

Book ID: 117263362
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 114 KB
Volume: 57
Category: Article
ISSN: 0090-4295
DOI: 10.1016/s0090-4295(00)00948-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antioxidant dietary supplements: Rationa

Antioxidant dietary supplements: Rationale and current status as chemopreventive agents for prostate cancer

✍ Neil Eric Fleshner; Omer Kucuk 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 122 KB

Tyrosine kinase inhibitors and signal tr

Tyrosine kinase inhibitors and signal transduction modulators: Rationale and current status as chemopreventive agents for prostate cancer

✍ Raymond C Bergan; Doyle H Waggle; Stephen K Carter; Ivan Horak; William Slichenm 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Novel COX-2 inhibitors as cancer chemopr

Novel COX-2 inhibitors as cancer chemopreventive and antiangiogenic agents

✍ Lawrence J. Marnett; Amit Kalgutkar; Brenda Crews; Kevin Kozak; Scott Rowlinsot; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Flavonoids and Other Compounds from Oura

Flavonoids and Other Compounds from Ouratea ferruginea (Ochnaceae) as Anticancer and Chemopreventive Agents

✍ Fidelis, Queli C.; Castro, Rosane N.; Guilhon, Giselle M. S. P.; Rodrigues, Silv 📂 Article 📅 2012 🏛 Molecular Diversity Preservation International 🌐 English ⚖ 226 KB

Androgen deprivation therapy for prostat

Androgen deprivation therapy for prostate cancer chemoprevention: current status and future directions for agent development

✍ Ronald Lieberman 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 275 KB

Jak2 inhibitors: Rationale and role as t

Jak2 inhibitors: Rationale and role as therapeutic agents in hematologic malignancies

✍ Jacqueline Sayyah; Peter P. Sayeski 📂 Article 📅 2009 🏛 Current Science Inc. 🌐 English ⚖ 359 KB